← Human Trials & Peer-Reviewed Studies
Effects of Vitamin D Supplementation on Disabling Foot Pain in Patients With Symptomatic Knee Osteoarthritis.
Plain-language guide to PMID 32623812 (2021): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 2 patients.
Key Facts
- PMID
- 32623812
- Journal
- Arthritis care & research
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Tu L et al. (12 authors)
- DOI
- 10.1002/acr.24371
- Registered trial
- NCT01176344
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Manchester Foot Pain and Disability Index (MFPDI) was used to evaluate foot pain and disabling foot pain was defined as at least 1 of the 10 functional limitation items (items 1-9 and 11) being documented as on "most/every day(s)" in the last month.
Who Took Part
According to the abstract, 2 patients were involved.
The age groups tagged for this paper are middle-aged adults and older adults, both men and women.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Neither the patients nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
A post hoc study was conducted from a randomized, double-blind, placebo-controlled trial named the Vitamin D Effect on Osteoarthritis (VIDEO) study.
A repeated-measures, mixed-effects model was used to analyze the change of MFPDI scores between groups adjusting for potential confounders.
What Was Measured
Topics PubMed links to this paper include Arthralgia, Biomarkers, Cholecalciferol, Dietary Supplements, Disability Evaluation, Foot Joints and Osteoarthritis, Knee.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 2 patients.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2021 (Arthritis care & research), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.